Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Warrants and options expiring

<< Previous

Bullboard Posts

Next >>

Comment by 2b7f6fabon Jun 07, 2024 11:35am

161 Views

Post# 36077674

RE:Warrants and options expiring

My comment about Bencro was tonque in cheek,
Anyways, if a party was interested in acquiring the technology for say $1 billion, then fully diluted would receive approx $3/sh or if after September $4/sh.
I'm just not sure how we get out of this low share price trap. BTD still seems months away :(

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market